The study found no significant association between OC and breast cancer risk for BRCA1 (RR = 1.09; 95% CI 0.77–1.54) and BRCA2 mutation carriers (RR = 1.15; 95% CI 0.61–2.18). The gene discussed is BRCA2; the disease is breast carcinoma.